Bellevue Life Sciences Acquisition Total Assets

Bellevue Life Sciences Acquisition posts a total assets of $170M as of March 2026. That compares with $170M in the prior-year period — down 1.4% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Bellevue Life Sciences Acquisition's total assets was $170M. The latest reading is $170M — a 1.4% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Total Assets is one piece of Bellevue Life Sciences Acquisition's financial statement story. At $170M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BLAC's total assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Bellevue Life Sciences Acquisition's other metric pages and overview cover the third.